We propose to continue our research on the? function of the endothelial storage granules called Weibel-Palade bodies (WPBs)? and also include studies of the related platelet granules. We will explore the role of these granules both in homeostasis and in mouse disease models of acute and chronic inflammation, thrombotic thrombocytopenic purpura and stroke. The project will consist of three interrelated Specific Aims. In the first Aim, new roles of Weibel-Palade body components in inflammation and wound healing will be ad? dressed. We propose to examine the role of von Willebrand factor (VWF) in leukocyte adhesion and recruitment to sites of inflammation. This is based on our documentation of increased leukocyte rolling in mice lacking the metalloprotease ADA? MTS13 which reduces the biological activity of secreted VWF. We also propose to? explore the vascular functions of Angiopoietin-2 (Ang-2), a recently recognized? component of WPBs. Using Ang-2 -/- mice, we will address the role of Ang-2 in wound healing and inflammatory responses including lymphangiogenesis. In the second aim, we will perform studies of vessels during inflammation and the role of platelet and endothelial granules in vessel stability and prevention of hemorrhage? .
This aim i s based on our surprising observation of massive hemorrhage in micro? circulation at sites of inflammation in thrombocytopenic mice. We will evaluate? the role of platelet adhesion, platelet microparticles and platelet granules in? endothelial stabilization. Emphasis will be given to the importance of the balance between platelet Angiopoietin-1 and vascular Angiopoietin-2, molecules regulating vascular stability in opposing ways, and the possible role of platelet serotonin in preventing inflammatory hemorrhage. In addition, the function of platelet serotonin in inflammation, angiogenesis and wound healing will be studied in? mice deficient in a key enzyme needed for peripheral serotonin production, tryptophan hydroxylase 1. In the third aim we will examine the role of Weibel-Palade? bodies and ADAMTS13 in stroke and stroke recovery.
This aim i s based on the fact? that ischemia/reperfusion, such as occurs in thrombotic stroke, induces WPB secretion and on our preliminary result pointing to an important role for VWF in stroke-induced injury. We will examine the effect of elevated plasma VWF and ADAMT? S13-deficiency on the outcome of stroke and test recombinant ADAMTS13 as a new candidate for stroke therapy. We will also explore the role of Angiopoietin-2 in? stroke injury, stroke-induced angiogenesis and recovery from brain injury. We hope that our studies will further clarify the role of WPBs in normal tissue repair and in inflammatory and thrombotic diseases. The components of WPBs are key targets for drug development. Thus an exact understanding of their involvement in? these processes is essential.

Public Health Relevance

We propose to study the function of molecules stored in Weibel-Palade bodies, vesicles within the cells of blood vessels. The contents of these vesicles are released during injury where? the released molecules help in tissue repair. The Weibel-Palade bodies are also? released in pathological situations and then they promote heart disease, inflammation and stroke. We will investigate how inhibition of a particular component? of these vesicles could improve outcome in these major diseases. ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL041002-21
Application #
7242626
Study Section
Special Emphasis Panel (NSS)
Program Officer
Link, Rebecca P
Project Start
1988-07-01
Project End
2009-06-30
Budget Start
2007-07-01
Budget End
2009-06-30
Support Year
21
Fiscal Year
2007
Total Cost
$633,008
Indirect Cost
Name
Immune Disease Institute, Inc.
Department
Type
DUNS #
059709394
City
Boston
State
MA
Country
United States
Zip Code
02115
Carbo, Carla; Yuki, Koichi; Demers, Melanie et al. (2013) Isoflurane inhibits neutrophil recruitment in the cutaneous Arthus reaction model. J Anesth 27:261-8
Crescente, Marilena; Thomas, Grace M; Demers, Melanie et al. (2012) ADAMTS13 exerts a thrombolytic effect in microcirculation. Thromb Haemost 108:527-32
Demers, Melanie; Ho-Tin-Noe, Benoit; Schatzberg, Daphne et al. (2011) Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice. Cancer Res 71:1540-9
Zhao, Bing-Qiao; Chauhan, Anil K; Canault, Matthias et al. (2009) von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. Blood 114:3329-34
Ho-Tin-Noe, Benoit; Goerge, Tobias; Wagner, Denisa D (2009) Platelets: guardians of tumor vasculature. Cancer Res 69:5623-6
Ho-Tin-Noe, Benoit; Carbo, Carla; Demers, Melanie et al. (2009) Innate immune cells induce hemorrhage in tumors during thrombocytopenia. Am J Pathol 175:1699-708
Bergmeier, Wolfgang; Oh-Hora, Masatsugu; McCarl, Christie-Ann et al. (2009) R93W mutation in Orai1 causes impaired calcium influx in platelets. Blood 113:675-8
Cifuni, Stephen M; Wagner, Denisa D; Bergmeier, Wolfgang (2008) CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets. Blood 112:1696-703
Chauhan, Anil K; Walsh, Meghan T; Zhu, Guojing et al. (2008) The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis. Blood 111:3452-7
Chauhan, Anil K; Kisucka, Janka; Cozzi, Maria R et al. (2008) Prothrombotic effects of fibronectin isoforms containing the EDA domain. Arterioscler Thromb Vasc Biol 28:296-301

Showing the most recent 10 out of 55 publications